Table 2. Relationship between the expression of DSG2 and clinicopathological features in LUAD based on the TCGA.
| Clinicopathological features | n | Mean ± SD | p-value | |
|---|---|---|---|---|
| Age (years) | <60 ≥60 |
136 358 |
6.441 ± 1.233 6.360 ± 1.084 |
0.419 |
| Gender | Male Female |
237 276 |
6.488 ± 1.180 6.283 ± 1.099 |
0.017* |
| Smoking history | No Yes |
12 499 |
6.648 ± 0.987 6.374 ± 1.145 |
0.439 |
| T | T1 T2 T3 T4 |
168 276 47 19 |
6.156 ± 1.041 6.436 ± 1.251 6.589 ± 0.776 6.898 ± 0.697 |
0.001** |
| N | N0 N1 N2 |
330 95 74 |
6.236 ± 1.180 6.538 ± 1.016 6.823 ± 1.047 |
<0.001** |
| M | M0 M1 |
344 25 |
6.423 ± 1.109 6.473 ± 0.804 |
0.786 |
| TNM tumor Stage | I II III IV |
274 121 84 26 |
6.173 ± 1.193 6.522 ± 1.096 6.798 ± 1.010 6.500 ± 0.801 |
<0.001** |
Notes.
*
p < 0.05.
**
p < 0.01.
- T
- tumor
- N
- node
- M
- metastasis
- TNM
- , tumor-node-metastasis
- SD
- standard deviation